Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 29 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Yavropoulou, Maria P [Clear All Filters]
Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis..
J Clin Densitom. 20(4), 490-497.
(2017). Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss..
Biomedicines. 9(4),
(2021). Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass..
J Musculoskelet Neuronal Interact. 19(3), 253-257.
(2019).
(2021). Combination and sequential treatment in women with postmenopausal osteoporosis..
Expert Opin Pharmacother. 21(4), 477-490.
(2020). Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation..
Calcif Tissue Int.
(2021). Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor..
Endocrinol Diabetes Metab Case Rep. 2018,
(2018). The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation..
J Clin Endocrinol Metab.
(2021). Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs..
Neurosci Lett. 460(2), 148-51.
(2009). Effect of intracerebroventricular infusion of neurotensin in glucose-dependent insulinotropic peptide secretion in dogs..
Peptides. 31(1), 150-4.
(2010). The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis..
Bone. 158, 116354.
(2022). The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited..
Seizure. 48, 36-43.
(2017). Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation..
J Clin Densitom.
(2021). Expression pattern of the Hedgehog signaling pathway in pituitary adenomas..
Neurosci Lett. 611, 94-100.
(2016). Hypophosphatasia..
J Clin Med. 10(23),
(2021). The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study..
J Womens Health (Larchmt). 20(6), 971-6.
(2011). Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell Disease..
Hemoglobin. 41(1), 6-11.
(2017). Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study..
J Clin Med. 12(16),
(2023). Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?.
Calcif Tissue Int. 103(1), 107-108.
(2018). Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6..
Hormones (Athens). 11(1), 104-8.
(2012). Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations..
Maturitas. 147, 19-25.
(2021). Postprandial response of bone turnover markers in patients with Crohn's disease..
World J Gastroenterol. 20(28), 9534-40.
(2014). The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection..
Osteoporos Int.
(2023). The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia..
Clin Endocrinol (Oxf). 74(3), 306-11.
(2011).
(2018).